Neuroone Medical Technologies is trading -9.06% lower at $1.52 after no new company-specific announcement was identified for September 3, 2026.
- The latest identified major catalyst was the August 13, 2026 fiscal Q3 results, not an overnight release.
- Broad market conditions are mixed, offering no clear macro explanation for the decline.
- The move appears unexplained pending delayed news or additional filings.